Static Chart Simcere Pharmaceutical Group Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
5.73 ^HKD	-0.69%		+1.06%	-14.86%

06-25	Simcere-Mabpharm Cancer Drug Gets Marketing Approval in China	MT
06-25	Simcere Pharmaceutical Group Limited and Mabpharm Limited Announce Approval on the Marketing of ENLITUO in China by the National Medical Products Administration of China	CI

Duration

Period